Value-based insurance design

被引:250
作者
Chernew, Michael E. [1 ]
Rosen, Allison B.
Fendrick, A. Mark
机构
[1] Harvard Univ, Boston, MA 02115 USA
[2] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1377/hlthaff.26.2.w195
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
When everyone is required to pay the same out-of-pocket amount for health care services whose benefits depend on patient characteristics, there is enormous potential for both under- and overuse. Unlike most current health plan designs, Value-Based Insurance Design (VBID) explicitly acknowledges and responds to patient heterogeneity. It encourages the use of services when the clinical benefits exceed the cost and likewise discourages the use of services when the benefits do not justify the cost. This paper makes the case for VBID and outlines current VBID initiatives in the private sector as well as barriers to further adoption.
引用
收藏
页码:W195 / W203
页数:9
相关论文
共 25 条
  • [1] ARROW KJ, 1963, AM ECON REV, V53, P941
  • [2] Chernew ME, 2006, AM J MANAG CARE, V12, P150
  • [3] Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P173, DOI 10.1331/108658003321480713
  • [4] Fendrick AM, 2001, AM J MANAG CARE, V7, P861
  • [5] Fendrick AM, 2006, AM J MANAG CARE, V12, P18
  • [6] Cost-effectiveness and evidence evaluation as criteria for coverage policy
    Garber, AM
    [J]. HEALTH AFFAIRS, 2004, 23 (04) : W284 - W296
  • [7] Gibson TB, 2005, AM J MANAG CARE, V11, P730
  • [8] Pharmacy benefits and the use of drugs by the chronically ill
    Goldman, DP
    Joyce, GF
    Escarce, JJ
    Pace, JE
    Solomon, MD
    Laouri, M
    Landsman, PB
    Teutsch, SM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (19): : 2344 - 2350
  • [9] Goldman DP, 2006, AM J MANAG CARE, V12, P21
  • [10] Reporting clinical trial results to inform providers, payers, and consumers
    Hayward, RA
    Kent, DM
    Vijan, S
    Hofer, TP
    [J]. HEALTH AFFAIRS, 2005, 24 (06) : 1571 - 1581